...
首页> 外文期刊>Journal of pediatric hematology/oncology: Official journal of the American Society of Pediatric Hematology/Oncology >Bone health evaluation of children and adolescents with homozygous β-thalassemia: Implications for practice
【24h】

Bone health evaluation of children and adolescents with homozygous β-thalassemia: Implications for practice

机译:纯合β地中海贫血儿童和青少年的骨骼健康评估:对实践的启示

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVE: Bone tissue is adversely affected in patients with homozygous β-thalassemia. The aim of this study was to find warning signs of bone loss in young patients with β-thalassemia and allow prompt therapeutic interventions. METHODS: Thirty-eight patients were studied, 20 boys and 18 girls, aged 5 to 18 years (median=14.13 y), on regular transfusions and chelation treatments. Their bone mineral density (BMD) was measured with dual x-ray absorptiometry. The recorded parameters were weight, height, bone age (BA), transfusion adequacy (mean fetal hemoglobin value), and chelation efficacy (mean ferritin value, compliance). Tanner stage was also evaluated: 8 prepubertal subjects (stage 1), 18 peripubertal subjects (stages 2 and 3), and 12 postpubertal patients (stages 4 and 5). Blood and urine samples were collected for biochemical analysis. RESULTS: Mean BMD z score was -1.56±1.25. Thirteen patients had normal BMD (z score >-1), 17 patients had low BMD (z score: -1 up to -2.4), and 8 patients had very low BMD (z score <-2.5). Low BMD was observed in patients older than 12 years and was associated with short stature (r=0.33, P=0.04), delayed BA (r=0.61, P=0.01), and increased bone formation markers. There was no correlation of BMD z score with sex, fetal hemoglobin value, ferritin, and compliance. Regarding Tanner stage, it was associated strongly with short stature (r=0.57, P=0.01), ferritin (r=-0.38, P=0.02), and compliance (r=0.58, P=0.01). CONLUSIONS: The decline in BMD may start early, even in the well-transfused patients. This study targets the young patients who are mostly at the risk for bone loss, that is short adolescents with delayed BA. Their prompt recognition in everyday practice is important, as they will need close monitoring of their BMD and metabolic bone profile. In addition, therapeutic interventions, such as adequate calcium intake and sunlight exposure, weight-bearing exercise and, in cases of vitamin D insufficiency, proper supplementation could be suggested.
机译:目的:纯合β地中海贫血患者的骨组织受到不利影响。这项研究的目的是寻找年轻的β地中海贫血患者的骨丢失的警告信号,并允许及时的治疗干预。方法:对38例患者进行了研究,其中20例男孩和18例女孩,年龄5至18岁(中位数= 14.13岁),接受常规输血和螯合治疗。他们的骨矿物质密度(BMD)用双X射线吸收法测量。记录的参数为体重,身高,骨龄(BA),输血充分性(平均胎儿血红蛋白值)和螯合功效(平均铁蛋白值,依从性)。还评估了Tanner阶段:8个青春期前受试者(1期),18个青春期周围受试者(2和3期)和12个青春期后患者(4和5期)。收集血液和尿液样本进行生化分析。结果:平均BMD z评分为-1.56±1.25。 13例BMD正常(z得分> -1),17例BMD低(z得分:-1至-2.4)和8例BMD极低(z得分<-2.5)。在12岁以上的患者中观察到BMD较低,这与身材矮小(r = 0.33,P = 0.04),BA延迟(r = 0.61,P = 0.01)和骨形成标志物增加有关。 BMD z评分与性别,胎儿血红蛋白值,铁蛋白和依从性没有相关性。关于Tanner阶段,它与矮小的身材(r = 0.57,P = 0.01),铁蛋白(r = -0.38,P = 0.02)和顺应性(r = 0.58,P = 0.01)密切相关。结论:即使在输血良好的患者中,BMD的下降也可能较早开始。这项研究针对的是最有骨丢失风险的年轻患者,即青春期短,BA延迟的患者。他们在日常实践中的迅速识别非常重要,因为他们将需要密切监测其BMD和代谢性骨分布。此外,建议采取治疗干预措施,例如摄入足够的钙和暴露在阳光下,进行负重运动以及在维生素D不足的情况下,建议适当的补充。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号